Natera’s corporate mission is to improve the management of diseases worldwide, including reproductive health, cancer, and organ transplant care. Natera is applying its expertise in detecting very small amounts of DNA in the blood (or cell-free DNA) to the early and precise detection of molecular residual disease in cancer patients.